SARAH KARPEN: Open Payments
NPI 1376992354 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$19,193 in 34 payments from 4 companies in 2025. Trend: 2023 $1,093 · 2024 $714 · 2025 $19,193
Consulting: $9,840Speaker / faculty: $5,688Travel & lodging: $2,933Food & beverage: $637Education: $95
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 24 | $10,945 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $8,109 |
| Astellas Pharma US Inc | 2 | $116 |
| ABBVIE INC. | 1 | $22 |
Products named: IMDELLTRA (AMG757), ALUNBRIG, LUMAKRAS, VENCLEXTA, Vyloy.
Industry payments across CA — which companies pay providers there.
